Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Jan 1;183(1):127–136. doi: 10.1084/jem.183.1.127

A structural transition in class II major histocompatibility complex proteins at mildly acidic pH

PMCID: PMC2192407  PMID: 8551215

Abstract

Peptide binding by class II major histocompatibility complex proteins is generally enhanced at low pH in the range of hydrogen ion concentrations found in the endosomal compartments of antigen- presenting cells. We and others have proposed that class II molecules undergo a reversible conformational change at low pH that is associated with enhanced peptide loading. However, no one has previously provided direct evidence for a structural change in class II proteins in the mildly acidic pH conditions in which enhanced peptide binding is observed. In this study, susceptibility to denaturation induced by sodium dodecyl sulfate (SDS) detergent or heat was used to probe the conformation of class II at different hydrogen ion concentrations. Class II molecules became sensitive to denaturation at pH 5.5-6.5 depending on the allele and experimental conditions. The observed structural transition was fully reversible if acidic pH was neutralized before exposure to SDS or heat. Experiments with the environment- sensitive fluorescent probe ANS (8-anilino-1-naphthalene-sulfonic acid) provided further evidence for a reversible structural transition at mildly acidic pH associated with an increase in exposed hydrophobicity in class II molecules. IAd conformation was found to change at a higher pH than IEd, IEk, or IAk, which correlates with the different pH optimal for peptide binding by these molecules. We conclude that pH regulates peptide binding by influencing the structure of class II molecules.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amigorena S., Drake J. R., Webster P., Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature. 1994 May 12;369(6476):113–120. doi: 10.1038/369113a0. [DOI] [PubMed] [Google Scholar]
  2. Avva R. R., Cresswell P. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity. 1994 Dec;1(9):763–774. doi: 10.1016/s1074-7613(94)80018-9. [DOI] [PubMed] [Google Scholar]
  3. Bethell R. C., Gray N. M., Penn C. R. The kinetics of the acid-induced conformational change of influenza virus haemagglutinin can be followed using 1,1'-bis(4-anilino-5-naphthalenesulphonic acid). Biochem Biophys Res Commun. 1995 Jan 5;206(1):355–361. doi: 10.1006/bbrc.1995.1049. [DOI] [PubMed] [Google Scholar]
  4. Blum J. S., Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3975–3979. doi: 10.1073/pnas.85.11.3975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boniface J. J., Allbritton N. L., Reay P. A., Kantor R. M., Stryer L., Davis M. M. pH affects both the mechanism and the specificity of peptide binding to a class II major histocompatibility complex molecule. Biochemistry. 1993 Nov 9;32(44):11761–11768. doi: 10.1021/bi00095a003. [DOI] [PubMed] [Google Scholar]
  6. Boniface J. J., Lyons D. S., Wettstein D. A., Allbritton N. L., Davis M. M. Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J Exp Med. 1996 Jan 1;183(1):119–126. doi: 10.1084/jem.183.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bénaroch P., Yilla M., Raposo G., Ito K., Miwa K., Geuze H. J., Ploegh H. L. How MHC class II molecules reach the endocytic pathway. EMBO J. 1995 Jan 3;14(1):37–49. doi: 10.1002/j.1460-2075.1995.tb06973.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cresswell P. Human B cells alloantigens; separation from other membrane molecules by affinity chromatography. Eur J Immunol. 1977 Sep;7(9):636–639. doi: 10.1002/eji.1830070911. [DOI] [PubMed] [Google Scholar]
  9. Dornmair K., Rothenhäusler B., McConnell H. M. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harb Symp Quant Biol. 1989;54(Pt 1):409–416. doi: 10.1101/sqb.1989.054.01.050. [DOI] [PubMed] [Google Scholar]
  10. Germain R. N., Hendrix L. R. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature. 1991 Sep 12;353(6340):134–139. doi: 10.1038/353134a0. [DOI] [PubMed] [Google Scholar]
  11. Germain R. N., Rinker A. G., Jr Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature. 1993 Jun 24;363(6431):725–728. doi: 10.1038/363725a0. [DOI] [PubMed] [Google Scholar]
  12. Goto Y., Calciano L. J., Fink A. L. Acid-induced folding of proteins. Proc Natl Acad Sci U S A. 1990 Jan;87(2):573–577. doi: 10.1073/pnas.87.2.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goto Y., Fink A. L. Conformational states of beta-lactamase: molten-globule states at acidic and alkaline pH with high salt. Biochemistry. 1989 Feb 7;28(3):945–952. doi: 10.1021/bi00429a004. [DOI] [PubMed] [Google Scholar]
  14. Harding C. V., Roof R. W., Allen P. M., Unanue E. R. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2740–2744. doi: 10.1073/pnas.88.7.2740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Haughton G., Arnold L. W., Bishop G. A., Mercolino T. J. The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev. 1986 Oct;93:35–51. doi: 10.1111/j.1600-065x.1986.tb01501.x. [DOI] [PubMed] [Google Scholar]
  16. Hughson F. M., Wright P. E., Baldwin R. L. Structural characterization of a partly folded apomyoglobin intermediate. Science. 1990 Sep 28;249(4976):1544–1548. doi: 10.1126/science.2218495. [DOI] [PubMed] [Google Scholar]
  17. Jensen P. E. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J Immunol. 1993 Apr 15;150(8 Pt 1):3347–3356. [PubMed] [Google Scholar]
  18. Jensen P. E. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J Exp Med. 1991 Nov 1;174(5):1111–1120. doi: 10.1084/jem.174.5.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jensen P. E. Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization. J Exp Med. 1992 Sep 1;176(3):793–798. doi: 10.1084/jem.176.3.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jensen P. E. Regulation of antigen presentation by acidic pH. J Exp Med. 1990 May 1;171(5):1779–1784. doi: 10.1084/jem.171.5.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kim K. J., Kanellopoulos-Langevin C., Merwin R. M., Sachs D. H., Asofsky R. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol. 1979 Feb;122(2):549–554. [PubMed] [Google Scholar]
  22. Lee J. M., Kay C. M., Watts T. H. Conformational changes in mouse MHC class II proteins at acidic pH. Int Immunol. 1992 Aug;4(8):889–897. doi: 10.1093/intimm/4.8.889. [DOI] [PubMed] [Google Scholar]
  23. Lee J. M., Watts T. H. On the dissociation and reassociation of MHC class II-foreign peptide complexes. Evidence that brief transit through an acidic compartment is not sufficient for binding site regeneration. J Immunol. 1990 Mar 1;144(5):1829–1834. [PubMed] [Google Scholar]
  24. Malcherek G., Gnau V., Jung G., Rammensee H. G., Melms A. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J Exp Med. 1995 Feb 1;181(2):527–536. doi: 10.1084/jem.181.2.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Marić M. A., Taylor M. D., Blum J. S. Endosomal aspartic proteinases are required for invariant-chain processing. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2171–2175. doi: 10.1073/pnas.91.6.2171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mellman I., Fuchs R., Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem. 1986;55:663–700. doi: 10.1146/annurev.bi.55.070186.003311. [DOI] [PubMed] [Google Scholar]
  27. Mouritsen S., Dalum I., Engel A. M., Svane I. M., Svendsen I., Werdelin O., Elsner H. MHC class II-bound self-peptides can be effectively separated by isoelectric focusing and bind optimally to their MHC class II restriction elements around pH 5.0. Immunology. 1994 Aug;82(4):529–534. [PMC free article] [PubMed] [Google Scholar]
  28. Mouritsen S., Hansen A. S., Petersen B. L., Buus S. pH dependence of the interaction between immunogenic peptides and MHC class II molecules. Evidence for an acidic intracellular compartment being the organelle of interaction. J Immunol. 1992 Mar 1;148(5):1438–1444. [PubMed] [Google Scholar]
  29. Nelson C. A., Petzold S. J., Unanue E. R. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1227–1231. doi: 10.1073/pnas.90.4.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Nowell J., Quaranta V. Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells. J Exp Med. 1985 Oct 1;162(4):1371–1376. doi: 10.1084/jem.162.4.1371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pedrazzini T., Sette A., Albertson M., Grey H. M. Free ligand-induced dissociation of MHC-antigen complexes. J Immunol. 1991 May 15;146(10):3496–3501. [PubMed] [Google Scholar]
  32. Qiu Y., Xu X., Wandinger-Ness A., Dalke D. P., Pierce S. K. Separation of subcellular compartments containing distinct functional forms of MHC class II. J Cell Biol. 1994 May;125(3):595–605. doi: 10.1083/jcb.125.3.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Quill H., Carlson L., Fox B. S., Weinstein J. N., Schwartz R. H. Optimization of antigen presentation to T cell hybridomas by purified Ia molecules in planar membranes. Ia molecule polymorphism determines the antigenic fine specificity of the response to cytochrome c peptides. J Immunol Methods. 1987 Apr 2;98(1):29–41. doi: 10.1016/0022-1759(87)90432-7. [DOI] [PubMed] [Google Scholar]
  34. Reay P. A., Wettstein D. A., Davis M. M. pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J. 1992 Aug;11(8):2829–2839. doi: 10.1002/j.1460-2075.1992.tb05350.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Riberdy J. M., Newcomb J. R., Surman M. J., Barbosa J. A., Cresswell P. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 1992 Dec 3;360(6403):474–477. doi: 10.1038/360474a0. [DOI] [PubMed] [Google Scholar]
  36. Roche P. A., Cresswell P. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature. 1990 Jun 14;345(6276):615–618. doi: 10.1038/345615a0. [DOI] [PubMed] [Google Scholar]
  37. Sadegh-Nasseri S., Germain R. N. A role for peptide in determining MHC class II structure. Nature. 1991 Sep 12;353(6340):167–170. doi: 10.1038/353167a0. [DOI] [PubMed] [Google Scholar]
  38. Sadegh-Nasseri S., Stern L. J., Wiley D. C., Germain R. N. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature. 1994 Aug 25;370(6491):647–650. doi: 10.1038/370647a0. [DOI] [PubMed] [Google Scholar]
  39. Saha R., Banik U., Bandopadhyay S., Mandal N. C., Bhattacharyya B., Roy S. An operator-induced conformational change in the C-terminal domain of the lambda repressor. J Biol Chem. 1992 Mar 25;267(9):5862–5867. [PubMed] [Google Scholar]
  40. Sette A., Southwood S., Miller J., Appella E. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J Exp Med. 1995 Feb 1;181(2):677–683. doi: 10.1084/jem.181.2.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sette A., Southwood S., O'Sullivan D., Gaeta F. C., Sidney J., Grey H. M. Effect of pH on MHC class II-peptide interactions. J Immunol. 1992 Feb 1;148(3):844–851. [PubMed] [Google Scholar]
  42. Shimonkevitz R., Kappler J., Marrack P., Grey H. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med. 1983 Aug 1;158(2):303–316. doi: 10.1084/jem.158.2.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Sidney J., Oseroff C., Southwood S., Wall M., Ishioka G., Koning F., Sette A. DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. J Immunol. 1992 Oct 15;149(8):2634–2640. [PubMed] [Google Scholar]
  44. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., Wiley D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994 Mar 17;368(6468):215–221. doi: 10.1038/368215a0. [DOI] [PubMed] [Google Scholar]
  45. Stern L. J., Wiley D. C. The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell. 1992 Feb 7;68(3):465–477. doi: 10.1016/0092-8674(92)90184-e. [DOI] [PubMed] [Google Scholar]
  46. Stryer L. Fluorescence spectroscopy of proteins. Science. 1968 Nov 1;162(3853):526–533. doi: 10.1126/science.162.3853.526. [DOI] [PubMed] [Google Scholar]
  47. Tampé R., McConnell H. M. Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-Ad. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4661–4665. doi: 10.1073/pnas.88.11.4661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tulp A., Verwoerd D., Dobberstein B., Ploegh H. L., Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature. 1994 May 12;369(6476):120–126. doi: 10.1038/369120a0. [DOI] [PubMed] [Google Scholar]
  49. Urban R. G., Chicz R. M., Strominger J. L. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J Exp Med. 1994 Aug 1;180(2):751–755. doi: 10.1084/jem.180.2.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Walmsley A. R., Martin G. E., Henderson P. J. 8-Anilino-1-naphthalenesulfonate is a fluorescent probe of conformational changes in the D-galactose-H+ symport protein of Escherichia coli. J Biol Chem. 1994 Jun 24;269(25):17009–17019. [PubMed] [Google Scholar]
  51. West M. A., Lucocq J. M., Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature. 1994 May 12;369(6476):147–151. doi: 10.1038/369147a0. [DOI] [PubMed] [Google Scholar]
  52. Wettstein D. A., Boniface J. J., Reay P. A., Schild H., Davis M. M. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J Exp Med. 1991 Jul 1;174(1):219–228. doi: 10.1084/jem.174.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Witt S. N., McConnell H. M. A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8164–8168. doi: 10.1073/pnas.88.18.8164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Yang A. S., Honig B. Structural origins of pH and ionic strength effects on protein stability. Acid denaturation of sperm whale apomyoglobin. J Mol Biol. 1994 Apr 15;237(5):602–614. doi: 10.1006/jmbi.1994.1258. [DOI] [PubMed] [Google Scholar]
  55. Ziegler H. K., Unanue E. R. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A. 1982 Jan;79(1):175–178. doi: 10.1073/pnas.79.1.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Ziegler K., Unanue E. R. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol. 1981 Nov;127(5):1869–1875. [PubMed] [Google Scholar]
  57. de Kroon A. I., McConnell H. M. Kinetics and specificity of peptide-MHC class II complex displacement reactions. J Immunol. 1994 Jan 15;152(2):609–619. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES